The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
Abstract
PURPOSE: We provide a contemporary review of bladder tumor markers and summarize their role as prognostic indicators. MATERIALS AND METHODS: A comprehensive review of the literature on prognostic markers for transitional cell carcinoma of the bladder was performed. RESULTS: Intense research efforts are being made to identify and characterize better various bladder cancers and their true biological potential. The need to predict which superficial tumors will recur or progress and which invasive tumors will metastasize has led to the identification of a variety of potential prognostic markers. Blood group antigens, tumor associated antigens, proliferating antigens, oncogenes, peptide growth factors and their receptors, cell adhesion molecules, tumor angiogenesis and angiogenesis inhibitors, and cell cycle regulatory proteins have recently been identified. The potential clinical applications of these tumor markers are under active investigation. Recent attention has focused on which tumor markers may predict the responsiveness of a particular bladder cancer to systemic chemotherapy. CONCLUSIONS: At present conventional histopathological evaluation of bladder cancer (tumor grade and stage) cannot predict accurately the behavior of most bladder tumors. With a better understanding of the cell cycle, and cell to cell and cell to extracellular matrix interactions as well as improved diagnostic techniques (immunohistochemistry), progress is being made to identify and characterize other potential prognostic markers for transitional cell carcinoma of the bladder. The ultimate goal is to develop reliable prognostic markers that will accurately predict not only the course but also the response of a tumor to therapy. This information may then be used to dictate more aggressive treatment for tumors that are likely to progress and less aggressive treatment for those that are unlikely to progress. In the future these biological markers may also be used in gene therapy for the treatment of bladder cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
Takeichi, M. (1991) · Science · doi:10.1126/science.2006419 · Cited by 3,284
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Gerdes, J., Schwab, U., Lemke, H., & Stein, H. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310104 · Cited by 2,788
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,003
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
The cadherins: cell-cell adhesion molecules controlling animal morphogenesis
Takeichi, M. (1988) · Development · doi:10.1242/dev.102.4.639 · Cited by 1,615
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,469
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204
Angiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
The neu oncogene encodes an epidermal growth factor receptor-related protein
Bargmann, C. I., Hung, M.-C., & Weinberg, R. A. (1986) · Nature · doi:10.1038/319226a0 · Cited by 1,117
Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
p53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating Cells
Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., & Elledge, S. J. (1995) · Science · doi:10.1126/science.7863329 · Cited by 1,032
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.2.261 · Cited by 903
Hakomori, S. (1985) · PubMed · Cited by 804
Horak, E. R., Klenk, N., Leek, R., LeJeune, S., Smith, K., Stuart, N., Harris, A. L., Greenall, M., & Stepniewska, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)93150-l · Cited by 800
Isolation and expression of a complementary DNA that confers multidrug resistance
Gros, P., Neriah, Y. B., Croop, J. M., & Housman, D. E. (1986) · Nature · doi:10.1038/323728a0 · Cited by 797
Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., & Yamamoto, T. (1986) · Science · doi:10.1126/science.3012781 · Cited by 796
Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer
Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S.-C., Nichols, P. W., Skinner, D. G., Jones, P. A., & Cote, R. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311903 · Cited by 783
Self-citationStructural Evidence for the Authenticity of the Human Retinoblastoma Gene
Fung, Y.-K. T., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H., & Benedict, W. F. (1987) · Science · doi:10.1126/science.2885916 · Cited by 780
Induction of WAF1/CIP1 by a p53-independent pathway.
Michieli, P., Chedid, M., Lin, D. P., Pierce, J. H., Mercer, W. E., & Givol, D. (1994) · PubMed · Cited by 768
Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2
Gimbrone, M. A., Cotran, R. S., Leapman, S. B., & Folkman, J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.413 · Cited by 758
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
Inhibition of Angiogenesis In Vivo by Interleukin 12
Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., & Folkman, J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.8.581 · Cited by 722
THE myc ONCOGENE: ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION
Cole, M. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.002045 · Cited by 705
Clark, A. N. G., Mankikar, G. D., & Gray, I. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91280-5 · Cited by 697
Role of integrins and other cell adhesion molecules in tumor progression and metastasis.
Albelda, S. Μ. (1993) · PubMed · Cited by 662
Monoclonal antibody Ki‐67: its use in histopathology
BROWN, D. C., & GATTER, K. C. (1990) · Histopathology · doi:10.1111/j.1365-2559.1990.tb00788.x · Cited by 639
Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D., Bander, N., Weiselberg, L. R., et al. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42494-3 · Cited by 627
Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.
Cordon‐Cardo, C. (1995) · PubMed · Cited by 607
Neal, D., Bennett, M., Hall, R., Marsh, C., Abel, P., Sainsbury, J. R. C., & Harris, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91386-8 · Cited by 604
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
Blood, C. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90014-r · Cited by 593
Growth of Multicell Spheroids in Tissue Culture as a Model of Nodular Carcinomas 2
(1971) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/46.1.113 · Cited by 585
Srivastava, A., Laidler, P., Davies, R. P., Horgan, K. J., & Hughes, L. E. (1988) · PubMed Central · Cited by 528
Sarkis, A. S., Dalbagni, G. M., Cordon‐Cardo, C., Zhang, Z., Sheinfeld, J., Fair, W. R., Herr, H. W., & Reuter, V. E. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.1.53 · Cited by 517
Massagué, J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43959-7 · Cited by 473
Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., & Folkman, J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.356 · Cited by 464
Esrig, D., Spruck, C., Nichols, P. W., Chaiwun, B., Steven, K. E., Groshen, S. G., Chen, S. C., Skinner, D. G., Jones, P. A., & Côté, R. J. (1993) · PubMed Central · Cited by 452
Self-citationBagchi, S., Weinmann, R., & Raychaudhuri, P. (1991) · Cell · doi:10.1016/0092-8674(91)90558-g · Cited by 426
Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor Prognosis
Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S.-C., Skinner, D. G., & Nichols, P. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1603 · Cited by 420
Self-citationThe role of c-myc in cell growth
Evan, G. I., & Littlewood, T. D. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80339-9 · Cited by 365
Polverini, P. J., & Leibovich, S. J. (1984) · PubMed · Cited by 360
Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.
Bringuier, P., Umbas, R., Schaafsma, H. E., Karthaus, H. F. M., Debruyne, F. M. J., & Schalken, J. A. (1993) · PubMed · Cited by 355
Epidermal growth factor receptors
Adamson, E. D., & Rees, A. R. (1981) · Molecular and Cellular Biochemistry · doi:10.1007/bf02359619 · Cited by 349
Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer
Cordon-Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z., & Reuter, V. E. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.16.1251 · Cited by 334
Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., CHURCH, P. A., Lamm, D. L., Lange, P. H., Messing, E. M., Pasciak, R. M., Reservitz, G. B., et al. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65851-8 · Cited by 331
Stern, D. F., Heffernan, P. A., & Weinberg, R. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1729 · Cited by 327
Grossfeld, G. D., Ginsberg, D. A., Stein, J. P., Bochner, B. H., Esrig, D., Nichols, P. W., Taylor, C. R., Cote, R. J., Groshen, S., Dunn, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.219 · Cited by 319
Self-citationDifferent angiogenic pathways characterize superficial and invasive bladder cancer.
O’Brien, T., Cranston, D., Fuggle, S., Bicknell, R., & Harris, A. L. (1995) · PubMed · Cited by 291
p53 and treatment of bladder cancer
Cote, R. J., Esrig, D., Groshen, S., Jones, P. A., & Skinner, D. G. (1997) · Nature · doi:10.1038/385123b0 · Cited by 269
Self-citationThrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.
Iruela-Arispe, M. L., Bornstein, P., & Sage, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5026 · Cited by 269
Sarkis, A. S., Bajorin, D. F., Reuter, V. E., Herr, H. W., Netto, G., Zhang, Z. F., Schultz, P. K., Cordon-Cardo, C., & Scher, H. I. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1384 · Cited by 254
Lipponen, P. K. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530304 · Cited by 253
FOLKMAN, J., COLE, P., & ZIMMERMAN, S. (1966) · Annals of Surgery · doi:10.1097/00000658-196609000-00012 · Cited by 247
Logothetis, C. J., Xu, H.-J., Ro, J. Y., Hu, S.-X., Sahin, A., Ordonez, N., & Benedict, W. F. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.16.1256 · Cited by 244
Molecular genetic alterations in superficial and locally advanced human bladder cancer.
Presti, J. C., Reuter, V. E., Galan, T. I., Fair, W. R., & Cordón-Cardó, C. (1991) · PubMed · Cited by 230
Tumor Angiogenesis Correlates with Lymph Node Metastases in Invasive Bladder Cancer
Jaeger, T. M., Weidner, N., Chew, K., Moore, D. H., Kerschmann, R. L., Waldman, F. M., & Carroll, P. R. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67230-6 · Cited by 228
The Petinoblastoma Tumor Suppressor Protein
(1994) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60834-9 · Cited by 219
Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth
O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Cao, Y., Moses, M., Lane, W. S., Sage, E. H., & Folkman, J. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.052 · Cited by 216
Expression and characterization of the human c-myc DNA-binding protein.
Watt, R. A., Shatzman, A. R., & Rosenberg, M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.3.448 · Cited by 212
Symington, B. E., Takada, Y., & Carter, W. G. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.2.523 · Cited by 208
Vallés, A. M., Boyer, B., Badet, J., Tucker, G. C., Barritault, D., & Thiery, J. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1124 · Cited by 207
Shimazui, T., Schalken, J. A., Giroldi, L. A., Jansen, C. F. J., Akaza, H., Koiso, K., Debruyne, F. M. J., & Bringuier, P. (1996) · PubMed · Cited by 202
Antigenic Deletion and Prognosis of Patients with Stage a Transitional Cell Bladder Carcinoma
Decenzo, J. M., Howard, P., & Irish, C. E. (1975) · The Journal of Urology · doi:10.1016/s0022-5347(17)67163-5 · Cited by 202
Berns, E., Klijn, J. G. M., van Putten, W. L., van Staveren, I. L., Portengen, H., & Foekens, J. A. (1992) · PubMed · Cited by 201
Altered Patterns of MDM2 and TP53 Expression in Human Bladder Cancer
Lianes, P., Orlow, I., Zhang, Z.-F., Oliva, M. R., Sarkis, A. S., Reuter, V. E., & Cordon-Cardo, C. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.17.1325 · Cited by 194
ERBB2 amplification in breast cancer with a high rate of proliferation.
Borg, Å., Baldetorp, B., Fernö, M., Killander, D., Olsson, H. L., & Sigurdsson, H. (1991) · PubMed · Cited by 188
Cairns, P., Proctor, A. J., & Knowles, M. A. (1991) · PubMed · Cited by 168
Lloyd, K. O. (1987) · American Journal of Clinical Pathology · doi:10.1093/ajcp/87.1.129 · Cited by 168
Evaluation of epidermal growth factor receptors in bladder tumours
Berger, M., Greenfield, C., Gullick, W., Haley, J., Downward, J., Neal, D., Harris, A., & Waterfield, M. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.238 · Cited by 165
Tissue Blood-Group Antigens and Prognosis in Low Stage Transitional Cell Carcinoma of the Bladder
Lange, P. H., Limas, C., & Fraley, E. E. (1978) · The Journal of Urology · doi:10.1016/s0022-5347(17)57379-6 · Cited by 155
HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
Lee, J., Dull, T. J., Lax, I., Schlessinger, J., & Ullrich, A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03361.x · Cited by 131
Jouanneau, J., Gavrilović, J., Caruelle, D., Jaye, M., Moens, G., Caruelle, J. P., & Thiery, J. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2893 · Cited by 127
King, E. D., Matteson, J., Jacobs, S. C., et al. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66652-7 · Cited by 110
Syrigos, K. N., Krausz, T. N., Waxman, J., Pandha, H., Rowlinson‐Busza, G., Verne, J., Epenetos, A. A., & Pignatelli, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640603 · Cited by 107
Transforming growth factor‐β: An important mediator of immunoregulation
Kehrl, J. H. (1991) · The International Journal Of Cell Cloning · doi:10.1002/stem.1991.5530090502 · Cited by 105
Newman, A. J., Carlton, C. E., & Johnson, S. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55275-1 · Cited by 105
Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumour suppressor genes
Stanley, L. A. (1995) · Toxicology · doi:10.1016/0300-483x(94)02991-3 · Cited by 104
Mulder, A., Hootegem, J. C. S. P. V., Sylvester, R. J., ten Kate, F. J. W., Kurth, K. H., Ooms, E. C. M., & van der Kwast, T. (1992) · The Journal of Pathology · doi:10.1002/path.1711660107 · Cited by 103
Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 Amplification
Habuchi, T., Kinoshita, H., Yamada, H., Kakehi, Y., Ogawa, O., Wu, W., Takahashi, R., Sugiyama, T., & Yoshida, O. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.17.1331 · Cited by 96
Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.
Barnhill, R. L., & Levy, M. A. (1993) · PubMed · Cited by 93
Sauter, G., Haley, J. D., Chew, K., KERSCHMANN, R. L., Moore, D. H., Carroll, P. R., Moch, H., Gudat, F. G., Mihatsch, M. J., & Waldman, F. M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570412 · Cited by 93
Hasegawa, S., Abe, T., Naito, S., Kotoh, S., Kumazawa, J., Hipfner, D. R., Deeley, R. G., Cole, S., & Kuwano, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.177 · Cited by 93
Okamura, K., Miyake, K., Koshikawa, T., & Asai, J. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39613-1 · Cited by 92
Role of myc amplification and overexpression in cell growth, differentiation and death.
Koskinen, P. J., & Alitalo, K. K. (1993) · PubMed · Cited by 89
Bush, C., Price, P., Norton, J., Parkins, C., Bailey, M. A., Boyd, J., Jones, C., A’Hern, R., & Horwich, A. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.306 · Cited by 85
Cordon‐Cardo, C., Reuter, V. E., Lloyd, K. O., Sheinfeld, J., Fair, W. R., Old, L. J., & Melamed, M. R. (1988) · PubMed · Cited by 78
Eder, I. E., Stenzl, A., Hobisch, A., Cronauer, M. V., Bartsch, G. C., & Klocker, H. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65670-2 · Cited by 76
Partanen, A. (1990) · PubMed · Cited by 75
BOND, J. A., Blaydes, J. P., Rowson, J., Haughton, M. F., Smith, J. R., Wynford‐Thomas, D., & Wyllie, F. S. (1995) · PubMed · Cited by 75
Geradts, J., Hu, S., Lincoln, C. E., Benedict, W. F., & Xu, H. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580203 · Cited by 72
Cell Proliferation of Human Bladder Tumors Determined by Brdurd and Ki-67 Immunostaining
Tsujihashi, H., Nakanishi, A., Matsuda, H., Uejima, S., & Kurita, T. (1991) · The Journal of Urology · doi:10.1016/s0022-5347(17)38475-6 · Cited by 68
Monoclonal Antibody Ki-67 in the Study of the Proliferative Activity of Bladder Carcinoma
Fontana, D., Bellina, M., Gubetta, L., Fasolis, G., Rolle, L., Scoffone, C. M., Porpiglia, F., Colombo, M. P., Tarabuzzi, R., & Leonardo, E. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36845-3 · Cited by 68
Nakagawa, M., Emoto, A., Nasu, N., Hanada, T., Kuwano, M., Cole, S. P. C., & Nomura, Y. (1997) · PubMed · Cited by 65
Lipponen, P. (1995) · The Journal of Pathology · doi:10.1002/path.1711750208 · Cited by 59
Proto-Oncogenes and Tumor Suppressor Genes in Human Urological Malignancies
Strohmeyer, T. G., & Slamon, D. J. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)35284-9 · Cited by 58
Partanen, A. (1990) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60083-6 · Cited by 58
Nakagawa, M., Emoto, A., Nasu, N., et al. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64944-9 · Cited by 56
Roux-Rouquié, M., Romain, S., Dussault, N., Desideri, C., Piana, L., Bonnier, P., Tubiana-Mathieu, N., & Martin, P. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90050-c · Cited by 51
Querrec, A. L., Duval, D., & Tobelem, G. (1993) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80195-7 · Cited by 45
Saito, T., Kimura, M., Kawasaki, T., Sato, S., & Tomita, Y. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.57 · Cited by 45
Evaluation of c-RAS Oncogene Product (p21 ) in Superficial Bladder Cancer
Fontana, D., Bellina, M., Scoffone, C. M., Cagnazzi, E., Cappia, S., Cavallo, F., Russo, R., & Leonardo, E. (1996) · European Urology · doi:10.1159/000473799 · Cited by 43
Point Mutations of c‐ras Genes in Human Bladder Cancer and Kidney Cancer
Nagata, Y., Abe, M., Kobayashi, K., Saiki, S., Kotake, T., Yoshikawa, K., Ueda, R., Nakayama, E., & Shiku, H. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02502.x · Cited by 40
The Monoclonal Antibody BQ16 Identifies the α6β4 Integrin on Bladder Cancer
Liebert, M., WEDEMEYER, G., STEIN, J. A., Washington, R. W., Waes, C. V., Carey, T. E., & Grossman, H. B. (1993) · Hybridoma · doi:10.1089/hyb.1993.12.67 · Cited by 35
Self-citationD’Elia, F. L., Cooper, H. S., & Mulholland, S. G. (1982) · The Journal of Urology · doi:10.1016/s0022-5347(17)53982-8 · Cited by 35
DEFINING THE IDEAL TUMOR MARKER FOR PROSTATE CANCER
Montie, J. E., & Meyers, S. (1997) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70369-4 · Cited by 26
Tumor Suppressor Gene Alterations in Bladder Carcinoma
Dalbagni, G. M., Cordon‐Cardo, C., Reuter, V. E., & Fair, W. R. (1995) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30450-2 · Cited by 25
Cited by
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A.-C., Boyd, S., Skinner, E., Bochner, B., Thangathurai, D., Mikhail, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.666 · Cited by 3,530
Self-citationOosterlinck, W., Lobel, B., Jakse, G., Malmström, P.-U., Stöckle, M., & Sternberg, C. (2002) · European Urology · doi:10.1016/s0302-2838(01)00026-4 · Cited by 464
Vlahou, A., Schellhammer, P. F., Mendrinos, S., Patel, K., Kondylis, F. I., Gong, L., Nasim, S., & Wright Jr., G. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64100-4 · Cited by 409
van Rhijn, B. W. G., Vis, A. N., van der Kwast, T. H., Kirkels, W. J., Radvanyi, F., Ooms, E. C. M., Chopin, D. K., Boevé, E. R., Jöbsis, A. C., & Zwarthoff, E. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.073 · Cited by 322
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
Malats, N., Bustos, A., Nascimento, C. M., Fernandez, F., Rivas, M., Puente, D., Kogevinas, M., & Real, F. X. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70315-6 · Cited by 317
Metadata
- Authors
- STEIN, J. P., GROSSFELD, G. D., GINSBERG, D. A., ESRIG, D., FREEMAN, J. A., FIGUEROA, A. J., SKINNER, D. G., & COTE, R. J.
- Venue
- Journal of Urology
- Published
- 1998-09
- Volume
- 160
- Issue
- 3 Part 1
- Pages
- 645-659
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2102917490
- Cited by
- 271
- References
- 119
- FWCI
- 25.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.